Literature DB >> 12149341

Role of corpus gastritis and cagA-positive Helicobacter pylori infection in reflux esophagitis.

Dulciene Maria Magalhães Queiroz1, Gifone Aguiar Rocha, Celso Affonso de Oliveira, Andreia Maria Camargos Rocha, Adriana Santos, Mônica Maria Demas Alvares Cabral, Ana Margarida Miguel Ferreira Nogueira.   

Abstract

Considering that the role of Helicobacter pylori infection in gastroesophageal reflux and reflux esophagitis (GERD) is still controversial and that the role of virulence markers of the bacterium has not been evaluated in most studies of GERD, we investigated the association among H. pylori infection with cagA-positive and -negative strains, corpus gastritis, and GERD in a large group of patients by controlling for confounding factors. We studied prospectively 281 consecutive adult patients: 93 with GERD and 188 controls. H. pylori infection status was diagnosed by culture, by the preformed urease test, with a carbolfuchsin-stained smear, and by histology. The cagA status was determined by PCR of H. pylori isolates and gastric biopsy specimens. H. pylori infection was diagnosed in 191 (68.0%) of 281 patients. Among the 93 patients with GERD, 84 presented with mild or moderate esophagitis and 9 presented with severe esophagitis. In the multivariate analysis, the age of the patients and the degree of oxyntic gastritis were associated with GERD. Among the strains isolated from patients with GERD and from the control group, 24.4 and 66.9%, respectively, were positive for cagA (P < 0.001). Compared to infection with cagA-negative strains, infection with cagA-positive H. pylori strains was associated with a more intense gastritis in the corpus (P = 0.001). cagA status (odds ratio [OR] = 0.16, 95% confidence interval [CI] = 0.07 to 0.40), gastritis of the corpus (OR = 0.69, 95% CI = 0.48 to 0.99), and age (OR = 1.04, 95% CI = 1.01 to 1.07) were associated with GERD. In conclusion, the study provides evidence supporting the independent protective roles of cagA-positive H. pylori strains and the degree of corpus gastritis against GERD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149341      PMCID: PMC120632          DOI: 10.1128/JCM.40.8.2849-2853.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection.

Authors:  N Vakil; B Hahn; D McSorley
Journal:  Aliment Pharmacol Ther       Date:  2000-01       Impact factor: 8.171

2.  Opposing time trends of peptic ulcer and reflux disease.

Authors:  H B el-Serag; A Sonnenberg
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

3.  Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases.

Authors:  C A Fallone; A N Barkun; M U Göttke; L M Best; V G Loo; S Veldhuyzen van Zanten; T Nguyen; A Lowe; T Fainsilber; K Kouri; R Beech
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

4.  Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East.

Authors:  J C Wu; J J Sung; E K Ng; M Y Go; W B Chan; F K Chan; W K Leung; C L Choi; S C Chung
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

5.  Corpus gastritis is protective against reflux oesophagitis.

Authors:  H B El-Serag; A Sonnenberg; M M Jamal; J M Inadomi; L A Crooks; R M Feddersen
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

6.  Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion.

Authors:  T Koike; S Ohara; H Sekine; K Iijima; Y Abe; K Kato; T Toyota; T Shimosegawa
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

7.  Helicobacter pylori infection, pattern of gastritis, and symptoms in erosive and nonerosive gastroesophageal reflux disease.

Authors:  G Manes; S Mosca; M Laccetti; M Lioniello; A Balzano
Journal:  Scand J Gastroenterol       Date:  1999-07       Impact factor: 2.423

8.  Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux.

Authors:  M Feldman; B Cryer; D Sammer; E Lee; S J Spechler
Journal:  Am J Physiol       Date:  1999-12

9.  Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?

Authors:  C A Fallone; A N Barkun; G Friedman; S Mayrand; V Loo; R Beech; L Best; L Joseph
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

10.  cagA-positive Helicobacter pylori and risk for developing gastric carcinoma in Brazil.

Authors:  D M Queiroz; E N Mendes; G A Rocha; A M Oliveira; C A Oliveira; P P Magalhães; S B Moura; M M Cabral; A M Nogueira
Journal:  Int J Cancer       Date:  1998-10-05       Impact factor: 7.396

View more
  5 in total

1.  Helicobacter pylori Serology Inversely Correlated With the Risk and Severity of Reflux Esophagitis in Helicobacter pylori Endemic Area: A Matched Case-Control Study of 5,616 Health Check-Up Koreans.

Authors:  Su Jin Chung; Seon Hee Lim; Jeongmin Choi; Donghee Kim; Young Sun Kim; Min Jeong Park; Jeong Yoon Yim; Joo Sung Kim; Sang-Heon Cho; Hyun Chae Jung; In Sung Song
Journal:  J Neurogastroenterol Motil       Date:  2011-07-13       Impact factor: 4.924

2.  Helicobacter pylori Has an Inverse Relationship With Severity of Reflux Esophagitis.

Authors:  Su Youn Nam
Journal:  J Neurogastroenterol Motil       Date:  2011-07-13       Impact factor: 4.924

3.  Gastroesophageal reflux disease in an area with low Helicobacter pylori infection prevalence.

Authors:  Muhammad Miftahussurur; Dalla Doohan; Iswan Abbas Nusi; Pangestu Adi; Yudith Annisa Ayu Rezkitha; Langgeng Agung Waskito; Kartika Afrida Fauzia; Taufan Bramantoro; Ummi Maimunah; Husin Thamrin; Safitri Indah Masithah; Sukadiono Sukadiono; Tomohisa Uchida; Maria Inge Lusida; Yoshio Yamaoka
Journal:  PLoS One       Date:  2018-11-14       Impact factor: 3.240

4.  Inverse correlation between gastroesophageal reflux disease and atrophic gastritis assessed by endoscopy and serology.

Authors:  Yoo Min Han; Su Jin Chung; Seokha Yoo; Jong In Yang; Ji Min Choi; Jooyoung Lee; Joo Sung Kim
Journal:  World J Gastroenterol       Date:  2022-02-28       Impact factor: 5.742

5.  Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates.

Authors:  Anita Paula Ortiz Godoy; Marcelo Lima Ribeiro; Yune Helena Borges Benvengo; Lea Vitiello; Maira de Carvalho Bueno Miranda; Sergio Mendonça; José Pedrazzoli
Journal:  BMC Gastroenterol       Date:  2003-08-11       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.